MedicalResearch.com—October 4, 2017
In a Q&A with MedicalResearch.com, HSS rheumatologist Anne R. Bass, MD discussed her recent study about how genetic testing helps determine the safest dose of a blood thinner for patients undergoing joint replacement surgery.
Dr. Bass explained that blood thinners are used to prevent blood clots from forming, but can be associated with serious bleeding complications if the wrong dose is given. During her study, she examined 1,600 patients undergoing surgery and gave those genetically guided doses as well as clinically guided doses.
Dr. Bass said the study showed that the use of genetic testing reduces the risk of complications including major bleeding, blood clotting and warfarin overdose.
Read the full article at medicalresearch.com